Cargando…
Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non–Small Cell Lung Cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995494/ https://www.ncbi.nlm.nih.gov/pubmed/29900027 |
| _version_ | 1783330633981886464 |
|---|---|
| author | Li, Shan Segal, Eve M. |
| author_facet | Li, Shan Segal, Eve M. |
| author_sort | Li, Shan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5995494 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Harborside Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59954942018-06-13 Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non–Small Cell Lung Cancer Li, Shan Segal, Eve M. J Adv Pract Oncol Review Article Harborside Press 2017-03 2017-03-01 /pmc/articles/PMC5995494/ /pubmed/29900027 Text en Copyright © 2017, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes. |
| spellingShingle | Review Article Li, Shan Segal, Eve M. Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non–Small Cell Lung Cancer |
| title | Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non–Small Cell Lung Cancer |
| title_full | Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non–Small Cell Lung Cancer |
| title_fullStr | Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non–Small Cell Lung Cancer |
| title_full_unstemmed | Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non–Small Cell Lung Cancer |
| title_short | Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non–Small Cell Lung Cancer |
| title_sort | osimertinib: a novel therapeutic option for overcoming t790m mutations in non–small cell lung cancer |
| topic | Review Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995494/ https://www.ncbi.nlm.nih.gov/pubmed/29900027 |
| work_keys_str_mv | AT lishan osimertinibanoveltherapeuticoptionforovercomingt790mmutationsinnonsmallcelllungcancer AT segalevem osimertinibanoveltherapeuticoptionforovercomingt790mmutationsinnonsmallcelllungcancer |